EHRA 2023: Late-Breaking Science Video Collection

Published: 18 April 2023

  • Views:

    Views Icon 2272

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice. 

More from this programme

Part 1

Expert Interviews

7 sessions
POTTER: Oesophageal Fistulae in Catheter Ablation Patients Watch now
AdaptResponse: AdaptivCRT® Algorithm in Synchronized LV Pacing Watch now
MANIFEST-PF: Real-world Experience of PFA in Commercial Practice Watch now
ANTWOORD II: LVEF Recovery After Atrial Fibrillation Ablation in Heart Failure Patients Watch now
TEMPO-HCM: Extended ECG Monitoring in HCM Watch now
Conformable PVI Catheter for Pulmonary Vein Isolation Watch now
BRUGADA Randomized: Epidcardial Ablation to Prevent Sudden Death Watch now

Part 2

Featured Highlights

In these concise overviews, selected faculty provide their thoughts on the most impactful trials from EHRA 2023. 

2 sessions
5 Trials That Will Change Your Practice With Dr Sohaib Watch now
4 Trials That Will Change Your Practice With Dr Di Biase Watch now

Part 3

Behind the Heart

Watch our Behind the Heart series to learn more about the personal perspectives of the investigators behind top trials in cardiovascular science.

5 sessions
Dr Bergonti: Pulsed-Field Ablation & Reasons to Research Watch now
Dr Bruce Wilkoff: Therapy Morbidity and Advice to Young Researchers Watch now
Dr Carlo Pappone: Advice to Early-Career Electrophysiologists Watch now
Dr Juan Caro Codon: Building a Team For Success Watch now
Dr Vivek Reddy: Pulsed-Field Ablation’s Transformative Impact and Advice For Young Researchers Watch now

About the episode

EHRA 2023 — Dr Vivek Y Reddy (Mount Sinai Hospital, US) shares the findings from a study looking at conformable PVI catheters for pulmonary vein isolation (PVI). The study investigates the use of a highly deformable mesh-like eight-french catheter that has recently received CE mark approval. The trial is ongoing at three centers.

Questions
1. What's the research context or rationale?
2. Describe the SpherePVI™ Catheter used.
3. Study design, outcome measures, and eligibility criteria?
4. What's next?

Recorded on-site at EHRA 2023, Barcelona. 

Faculty Biographies

Vivek Reddy

Vivek Reddy

Director of Cardiac Arrhythmia Services

Dr Vivek Y. Reddy is Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and Director of Electrophysiology for the Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at the Icahn School of Medicine at Mount Sinai.

Dr Reddy is one of the US's premier cardiac electrophysiologists. He leads a team of physician-scientists who are developing and testing advanced therapies for cardiac arrhythmias and heart failure, including catheter ablation for atrial fibrillation and ventricular tachycardia, and device therapies for stroke prevention. Under his leadership, Mount Sinai is the lead investigational site for many multinational clinical trials exploring new arrhythmia procedures and technologies, most recently pulsed field ablation to treat atrial fibrillation. Moreover, in 2014, he implanted the world’s first miniature leadless pacemaker, as well as the first leadless pacemaker in…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.